Media Room

Innovation in drug development isn't born from a single field of research or one technology alone. It emerges when scientists from diverse disciplines come together to share their knowledge and experiences. Dr. Park Young-min, director of the National New Drug Development Foundation, emphasized the need for collaboration that transcends boundaries between research fields and institutions to drive innovation in the drug development ecosystem. He stressed that translating groundbreaking discoveries in basic science into actual treatments and clinical benefits for patients requires a collaborative approach, where researchers from various fields work together to tackle complex scientific questions.

Dr. Park shared these insights during the 2026 Korea Drug Development Fund (KDDF) Science Conference, held from August 27 to 28 at the Alpensia Resort in Pyeongchang.

The KDDF Science Conference is an academic exchange event that brings together not only participants in national drug development projects but also experts from academia, industry, research institutions, and hospitals across the drug development landscape. To facilitate in-depth scientific discussions, the foundation organizes the conference as an invitation-only event, limited to about 100 participants.

Now in its sixth year, this year's conference focused on the theme, Transforming Science-Based Technology: From Discovery to Clinical Outcomes. A key topic of discussion was how to effectively translate scientific evidence gathered during the drug development process into tangible therapeutic advancements.